Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +20.00% and +3.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Artivion (AORT) Q2 Earnings Meet Estimates
Artivion (AORT) delivered earnings and revenue surprises of 0.00% and +4.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 24, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options...
PR Newswire
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +9.68% and +2.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Treace Medical Concepts (TMCI) to Release Earnings on Friday
Treace Medical Concepts (NASDAQ:TMCI) will be releasing its Q1 2026 earnings before the market opens on Friday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-8-treace-medical-concepts-inc-stock...
MarketBeat
Weber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCI
Weber Capital Management LLC ADV acquired a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 589,617 shares of the compa...
MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street Zen
Wall Street Zen upgraded Treace Medical Concepts from a "strong sell" rating to a "sell" rating in a research note on Monday...
MarketBeat
Wall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong Sell
Wall Street Zen cut Treace Medical Concepts from a "sell" rating to a "strong sell" rating in a research note on Sunday...
MarketBeat
Wall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to Sell
Wall Street Zen raised shares of Treace Medical Concepts from a "strong sell" rating to a "sell" rating in a report on Saturday...
MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have received an average recommendation of "Reduce" from the seven ratings firms that are covering the firm, Marketbeat Ratings...
MarketBeat

Advertisement|Remove ads.